Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-26-081
- Assistance listing (CFDA)
- 93.866
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
About this opportunity
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) that invites applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Applications will involve a well-integrated research program composed of a multidisciplinary team of investigators within a single institution or a consortium of institutions. Applications will demonstrate how the individual components will be synergistically integrated to advance understanding of the unifying hypothesis or theme. The structure and approach of proposed projects will vary depending on the hypotheses under investigation; however, all applications are expected to reflect a high level of coordination among c...
Related opportunities
- Center for Research on Complex Generics (U18) Clinical Trials OptionalFood and Drug AdministrationUp to $1.5M
- Collaborative Opportunities for Multiple-disciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)National Institutes of Health
- GREGoRi Innovation Projects (U01 Clinical Trial Optional)National Institutes of HealthCloses Oct 2026Up to $500K
- REACHing Communities (REACH) Consortium (U01) Clinical Trials OptionalFood and Drug AdministrationUp to $3.0M
- INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)National Institutes of HealthCloses Jun 2028
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)National Institutes of HealthCloses Nov 2028